Orthox Gains Funds for Knee Cartilage Clinical Trial

Orthox raised a further $4.3 million to close its $12.5 million Series A financing round. Proceeds will support additional clinical trials of its lead product, FibroFix™, in Hungary and the U.K.

Recruitment for the pivotal clinical trial will open later this year, with a first cohort of six patients and six-month follow-up. This will demonstrate...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us